UNIVERSITETI I MJEKESISE TIRANE

Their core work

The University of Medicine Tirana (UMT) is Albania's principal medical university, contributing clinical and public health expertise to EU research projects focused on preventive healthcare and chronic disease management. Their H2020 work centers on implementing scalable health screening programmes and digital health interventions in real-world primary care settings, particularly in lower-resource environments. They bring direct access to patient populations, primary healthcare networks, and clinical validation capacity in a Balkan country that bridges Western European and developing-world healthcare realities. Their practical contribution in consortium projects is typically field implementation, local data collection, and contextual adaptation of health interventions to community and family settings.

What they specialise in

How they've shifted over time

UMT's early H2020 work (2017-2021) was anchored in structured, protocol-driven screening programmes — specifically childhood vision and hearing — with a strong emphasis on cost-effectiveness and scalability in lower-middle-income countries. Their most recent project (2021-2026) marks a clear pivot toward digital tools, family-centred care, and lifestyle-driven self-management of chronic adult conditions such as diabetes and hypertension. The shift is from population-level screening logistics toward patient empowerment and digital health enablement, suggesting UMT is repositioning itself from a field implementation partner to a digitally-enabled community health actor.

UMT is moving from passive programme implementation toward active digital health partnerships, making them a credible candidate for future mHealth, telemedicine, or people-centred care consortia targeting underserved or transitional healthcare markets.

How they like to work

UMT has participated exclusively as a consortium partner — never as a coordinator — across both H2020 projects, suggesting they are comfortable operating as a contributing member rather than a project lead. Their 25 unique partners across 13 countries relative to only 2 projects indicates they join large, diverse international consortia rather than tight bilateral arrangements. This profile is typical of a clinical or public health institution valued for local access and implementation capacity rather than administrative or scientific coordination.

UMT has built connections with 25 distinct partner organisations across 13 countries through just two projects, which is a relatively broad network for a small H2020 footprint. Their geographic spread likely reflects the multi-country design of health screening and digital health trials that require nationally-diverse clinical sites.

What sets them apart

UMT is one of very few Albanian higher education institutions active in H2020 health research, giving them a rare position as an entry point for clinical and public health research into the Western Balkans — a region often sought by consortia needing to demonstrate EU-neighbourhood applicability. Their combination of medical university infrastructure and experience in both low-resource screening programmes and digital chronic disease tools is unusual for the region. For consortium builders, UMT offers credible local clinical validation, access to a non-EU patient population, and legitimacy for EU neighbourhood policy alignment.

Highlights from their portfolio

• EUSCREEN
  The largest of UMT's projects by funding (EUR 817K), focused on scaling childhood vision and hearing screening across middle-income countries — a rare combination of public health implementation and health economics in a multi-country RIA.
• DigiCare4You
  Marks UMT's entry into digital health and mHealth tools for chronic disease management, representing a significant thematic expansion and running until 2026 — their most current and forward-looking engagement.